Addition of bevacizumab to first-line chemotherapy in advanced colorectal cancer: a systematic review and meta-analysis, with emphasis on chemotherapy subgroups

BACKGROUND: Bevacizumab has an important role in first-line treatment of metastatic colorectal cancer. However, clinical trials studying its effect have involved distinct chemotherapy regimens with divergent results. The aim of this meta-analysis is to gather current data and evaluate not only the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Macedo, Ligia Traldi, da Costa Lima, Andre Bacellar, Sasse, Andre Deeke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350458/
https://www.ncbi.nlm.nih.gov/pubmed/22414244
http://dx.doi.org/10.1186/1471-2407-12-89

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350458/
https://www.ncbi.nlm.nih.gov/pubmed/22414244
http://dx.doi.org/10.1186/1471-2407-12-89

Ejemplares similares